Parkinson's disease motor symptoms rescue by CRISPRa‐reprogramming astrocytes into GABAergic neurons
Abstract Direct reprogramming based on genetic factors resembles a promising strategy to replace lost cells in degenerative diseases such as Parkinson's disease. For this, we developed a knock‐in mouse line carrying a dual dCas9 transactivator system (dCAM) allowing the conditional in vivo activatio...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Nature
2022-04-01
|
| シリーズ: | EMBO Molecular Medicine |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.15252/emmm.202114797 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
